|
End-of-day quote
Buenos Aires S.E.
2026-11-02
|
5-day change | 1st Jan Change | ||
| 136.00 ARS | -1.81% |
|
+0.37% | -43.45% |
| Market Cap | 5.79B 3.75M 3.35M 3.07M 2.79M 5.24M 355M 5.38M 36.7M 14.76M 187M 14.06M 13.76M 594M | P/E 2024 |
-3.67x | P/E 2025 | -2.23x |
|---|---|---|---|---|---|
| Enterprise Value | 6.53B 4.22M 3.77M 3.47M 3.15M 5.91M 400M 6.06M 41.37M 16.64M 211M 15.85M 15.51M 669M | EV / Sales 2024 |
0.73x | EV / Sales 2025 | 1.71x |
| Free-Float |
19.84% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -1.81% | ||
| 1 week | +0.37% | ||
| Current month | -1.81% | ||
| 1 month | -3.20% | ||
| 3 months | -14.73% | ||
| 6 months | -17.58% | ||
| Current year | -43.45% |
| 1 week | 130 |  | 144 |
| 1 month | 130 | | 154 |
| Current year | 128.5 | | 260 |
| 1 year | 128.5 | | 357 |
| 3 years | 46 | | 450 |
| 5 years | 9.1 | | 450 |
| 10 years | 4.2 | | 450 |
| Manager | Title | Age | Since |
|---|---|---|---|
Oscar Echeverria
DFI | Director of Finance/CFO | - | 2010-07-29 |
Federico Hoffman
CTO | Chief Tech/Sci/R&D Officer | - | - |
Eduardo Busto
ADM | Chief Administrative Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 2010-07-29 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.81% | +0.37% | -15.53% | +183.92% | 3.75M | |
| +0.56% | +10.92% | +58.60% | +150.42% | 1,257B | |
| -1.19% | -0.56% | +43.47% | +76.58% | 651B | |
| -0.60% | +0.56% | +35.84% | +103.59% | 510B | |
| -1.56% | -2.01% | +50.67% | +64.81% | 388B | |
| -2.55% | +2.08% | +75.49% | +40.03% | 366B | |
| -0.02% | +2.11% | +32.16% | +57.79% | 303B | |
| -0.72% | +7.32% | +11.29% | +33.98% | 288B | |
| -0.69% | +3.39% | +56.30% | +71.62% | 252B | |
| -0.57% | +6.67% | +39.03% | +107.98% | 211B | |
| Average | -0.86% | +4.10% | +38.73% | +89.07% | 422.67B | |
| Weighted average by Cap. | -0.53% | +5.30% | +48.02% | +94.57% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 8.27B 5.35M 4.78M 4.39M 3.99M 7.49M 507M 7.68M 52.43M 21.09M 268M 20.09M 19.66M 848M | 6.4B 4.14M 3.7M 3.4M 3.09M 5.8M 392M 5.94M 40.57M 16.32M 207M 15.55M 15.21M 656M |
| Net income | -1.42B -917K -819K -752K -683K -1.28M -86.84M -1.32M -8.98M -3.61M -45.83M -3.44M -3.37M -145M | -4.6B -2.97M -2.66M -2.44M -2.22M -4.16M -282M -4.27M -29.13M -11.72M -149M -11.16M -10.92M -471M |
| Net Debt | 863M 558K 499K 458K 416K 781K 52.89M 801K 5.47M 2.2M 27.91M 2.1M 2.05M 88.47M | 738M 477K 426K 392K 356K 668K 45.2M 685K 4.67M 1.88M 23.86M 1.79M 1.75M 75.62M |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-02 | ARS 136.00 | -1.81% | 3,263 |
| 26-10-30 | ARS 138.50 | -0.72% | 10,354 |
| 26-10-29 | ARS 139.50 | +2.57% | 1,200 |
| 26-10-28 | ARS 136.00 | -0.37% | 10,969 |
| 26-10-27 | ARS 136.50 | +0.74% | 17,143 |
- Stock Market
- Stocks
- ROSE Stock
Select your edition
All financial news and data tailored to specific country editions
